Skip to main content

Table 3 Proportion of patients with baseline bronchodilator responsiveness according to GOLD severity stage.

From: Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial

GOLD Stage

n

Criterion A

Criterion B

Criterion C

II

2694

1714 (64%)

1735 (64%)

1404 (52%)

III

2580

1226 (48%)

1738 (64%)

798 (31%)

IV

506

93 (18%)

315 (62%)

28 (6%)

All

5783

3033 (52%)

3788 (66%)

2230 (39%)

  1. GOLD = Global Initiative for Chronic Obstructive Lung Disease